Colleen Moretti | Authors

Black Patients with Metastatic Breast Cancer Less Likely to Trust, Participate in Clinical Trials

May 26, 2022

A Black patient with metastatic breast cancer explained that the results of the survey show that more work must be done by all stakeholders to increase the participation in clinical trials to accurately assess treatments in diversified populations.

Updated CAPTIVATE Data Continue to Show Benefit of Fixed-Duration Ibrutinib-Venetoclax in First-line CLL

December 11, 2021

Patients with chronic lymphocytic leukemia who were treated with ibrutinib and venetoclax in the first line continued to demonstrate deep, durable responses with new data showing further benefit to continuous ibrutinib therapy after 2 years.